Serving pharmaceutical patients throughout the Roanoke, Virginia, area, Ashok Pinnamaraju has a strong knowledge of the needs of senior patients, and regularly visits nursing homes. Though his work with seniors, Ashok Pinnamaraju has experience with drugs that address the cognitive symptoms associated with Alzheimer’s disease.
There are two basic types of FDA-approved medications designed to mitigate confusion and memory loss: cholinesterase inhibitors, and memantine. The latter regulates activities of the chemical glutamate, which is critical in information processing, and enables some people to think more clearly and better perform daily activities. Common side effects include dizziness, constipation, and headache.
By contrast, cholinesterase inhibitors work to prevent the memory and learning-related chemical messenger acetylcholine from breaking down. This promotes high levels of acetylcholine, associated with proper nerve cell communication. Typically tolerated well by the body, cholinesterase inhibitors occasionally have side effects such as appetite loss, nausea, and an increase in bowel movement frequency.